Canaccord Genuity Downgrades GenMark Diagnostics (GNMK) to Hold, Following Acquisition
Tweet Send to a Friend
Canaccord Genuity analyst Max Masucci downgraded GenMark Diagnostics (NASDAQ ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
